Literature DB >> 22223854

Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis.

David J Horne1, April K Randhawa, Tran T H Chau, Nguyen D Bang, Nguyen T B Yen, Jeremy J Farrar, Sarah J Dunstan, Thomas R Hawn.   

Abstract

BACKGROUND: Tuberculosis has been associated with genetic variation in host immunity. We hypothesized that single-nucleotide polymorphisms (SNPs) in SIGIRR, a negative regulator of Toll-like receptor/IL-1R signaling, are associated with susceptibility to tuberculosis.
METHODS: We used a case-population study design in Vietnam with cases that had either tuberculous meningitis or pulmonary tuberculosis. We genotyped 6 SNPs in the SIGIRR gene region (including the adjacent genes PKP3 and TMEM16J) in a discovery cohort of 352 patients with tuberculosis and 382 controls. Significant associations were genotyped in a validation cohort (339 patients with tuberculosis, 376 controls).
RESULTS: Three SNPs (rs10902158, rs7105848, rs7111432) were associated with tuberculosis in discovery and validation cohorts. The polymorphisms were associated with both tuberculous meningitis and pulmonary tuberculosis and were strongest with a recessive genetic model (odds ratios, 1.5-1.6; P = .0006-.001). Coinheritance of these polymorphisms with previously identified risk alleles in Toll-like receptor 2 and TIRAP was associated with an additive risk of tuberculosis susceptibility.
CONCLUSIONS: These results demonstrate a strong association of SNPs in the PKP3-SIGIRR-TMEM16J gene region and tuberculosis in discovery and validation cohorts. To our knowledge, these are the first associations of polymorphisms in this region with any disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223854      PMCID: PMC3266131          DOI: 10.1093/infdis/jir785

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

1.  Use of unlinked genetic markers to detect population stratification in association studies.

Authors:  J K Pritchard; N A Rosenberg
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.

Authors:  David Wald; Jinzhong Qin; Zhendong Zhao; Youcun Qian; Mayumi Naramura; Liping Tian; Jennifer Towne; John E Sims; George R Stark; Xiaoxia Li
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

Review 3.  Genetic susceptibility to tuberculosis.

Authors:  Richard Bellamy
Journal:  Clin Chest Med       Date:  2005-06       Impact factor: 2.878

4.  Genetic association studies.

Authors:  Heather J Cordell; David G Clayton
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

5.  A comparison of case-control and family-based association methods: the example of sickle-cell and malaria.

Authors:  H Ackerman; S Usen; M Jallow; F Sisay-Joof; M Pinder; D P Kwiatkowski
Journal:  Ann Hum Genet       Date:  2005-09       Impact factor: 1.670

6.  SIGIRR puts the brakes on Toll-like receptors.

Authors:  Luke A J O'Neill
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

7.  SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.

Authors:  Jinzhong Qin; Youcun Qian; Jianhong Yao; Cui Grace; Xiaoxia Li
Journal:  J Biol Chem       Date:  2005-05-02       Impact factor: 5.157

8.  Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.

Authors:  Guy E Thwaites; Duc Bang Nguyen; Huy Dung Nguyen; Thi Quy Hoang; Thi Tuong Oanh Do; Thi Cam Thoa Nguyen; Quang Hien Nguyen; Tri Thuc Nguyen; Ngoc Hai Nguyen; Thi Ngoc Lan Nguyen; Ngoc Lan Nguyen; Hong Duc Nguyen; Ngoc Tuan Vu; Huu Hiep Cao; Thi Hong Chau Tran; Phuong Mai Pham; Thi Dung Nguyen; Kasia Stepniewska; Nicholas J White; Tinh Hien Tran; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

9.  Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.

Authors:  Luis B Barreiro; Olivier Neyrolles; Chantal L Babb; Ludovic Tailleux; Hélène Quach; Ken McElreavey; Paul D van Helden; Eileen G Hoal; Brigitte Gicquel; Lluis Quintana-Murci
Journal:  PLoS Med       Date:  2006-01-03       Impact factor: 11.069

10.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

View more
  26 in total

1.  Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis.

Authors:  Javeed A Shah; Jay C Vary; Tran T H Chau; Nguyen D Bang; Nguyen T B Yen; Jeremy J Farrar; Sarah J Dunstan; Thomas R Hawn
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

2.  Common polymorphisms in the CD43 gene region are associated with tuberculosis disease and mortality.

Authors:  Monica Campo; April K Randhawa; Sarah Dunstan; Jeremy Farrar; Maxine Caws; Nguyen Duc Bang; Nguyen Ngoc Lan; Tran Thi Hong Chau; David J Horne; Nguyen Thuong Thuong; Guy E Thwaites; Thomas R Hawn
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

Review 3.  Protection versus pathology in tuberculosis: recent insights.

Authors:  Andrea M Cooper; Egidio Torrado
Journal:  Curr Opin Immunol       Date:  2012-05-19       Impact factor: 7.486

4.  A Coding Variant of ANO10, Affecting Volume Regulation of Macrophages, Is Associated with Borrelia Seropositivity.

Authors:  Christian Hammer; Podchanart Wanitchakool; Lalida Sirianant; Sergi Papiol; Mathieu Monnheimer; Diana Faria; Jiraporn Ousingsawat; Natalie Schramek; Corinna Schmitt; Gabriele Margos; Angelika Michel; Peter Kraiczy; Michael Pawlita; Rainer Schreiber; Thomas F Schulz; Volker Fingerle; Hayrettin Tumani; Hannelore Ehrenreich; Karl Kunzelmann
Journal:  Mol Med       Date:  2015-02-23       Impact factor: 6.354

5.  The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes.

Authors:  Andrew D Graustein; David J Horne; Jerry J Fong; Flavio Schwarz; Heather C Mefford; Glenna J Peterson; Richard D Wells; Munyaradzi Musvosvi; Muki Shey; Willem A Hanekom; Mark Hatherill; Thomas J Scriba; Nguyen Thuy Thuong Thuong; Nguyen Thi Hoang Mai; Maxine Caws; Nguyen Duc Bang; Sarah J Dunstan; Guy E Thwaites; Ajit Varki; Takashi Angata; Thomas R Hawn
Journal:  Tuberculosis (Edinb)       Date:  2017-02-21       Impact factor: 3.131

6.  TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam.

Authors:  A D Graustein; D J Horne; M Arentz; N D Bang; T T H Chau; G E Thwaites; M Caws; N T T Thuong; S J Dunstan; T R Hawn
Journal:  Tuberculosis (Edinb)       Date:  2015-01-07       Impact factor: 3.131

7.  Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients.

Authors:  Christina Thobakgale; Kewreshini Naidoo; Lyle R McKinnon; Lise Werner; Natasha Samsunder; Salim Abdool Karim; Thumbi Ndungʼu; Marcus Altfeld; Kogieleum Naidoo
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

Review 8.  Modulating Ca²⁺ signals: a common theme for TMEM16, Ist2, and TMC.

Authors:  Karl Kunzelmann; Ines Cabrita; Podchanart Wanitchakool; Jiraporn Ousingsawat; Lalida Sirianant; Roberta Benedetto; Rainer Schreiber
Journal:  Pflugers Arch       Date:  2015-12-23       Impact factor: 3.657

Review 9.  The pathogenesis of tuberculous meningitis.

Authors:  Angharad Grace Davis; Ursula Karin Rohlwink; Alizé Proust; Anthony A Figaji; Robert J Wilkinson
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

Review 10.  Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.

Authors:  Martina Molgora; Domenico Supino; Alberto Mantovani; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.